JP2010523678A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010523678A5 JP2010523678A5 JP2010503077A JP2010503077A JP2010523678A5 JP 2010523678 A5 JP2010523678 A5 JP 2010523678A5 JP 2010503077 A JP2010503077 A JP 2010503077A JP 2010503077 A JP2010503077 A JP 2010503077A JP 2010523678 A5 JP2010523678 A5 JP 2010523678A5
- Authority
- JP
- Japan
- Prior art keywords
- lyophilized solid
- solid formulation
- api
- formulation
- lyophilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07290443A EP1980240A1 (en) | 2007-04-11 | 2007-04-11 | Lyophilized pharmaceutical compositions and methods of making and using same |
| PCT/US2008/004755 WO2008127679A1 (en) | 2007-04-11 | 2008-04-11 | Lyophilized pharmaceutical compositions and methods of making and using same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014165583A Division JP2015028030A (ja) | 2007-04-11 | 2014-08-15 | 凍結乾燥薬学的組成物、及びその製造及び使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010523678A JP2010523678A (ja) | 2010-07-15 |
| JP2010523678A5 true JP2010523678A5 (enExample) | 2012-06-14 |
Family
ID=38477086
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010503077A Pending JP2010523678A (ja) | 2007-04-11 | 2008-04-11 | 凍結乾燥薬学的組成物、及びその製造及び使用方法 |
| JP2014165583A Pending JP2015028030A (ja) | 2007-04-11 | 2014-08-15 | 凍結乾燥薬学的組成物、及びその製造及び使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014165583A Pending JP2015028030A (ja) | 2007-04-11 | 2014-08-15 | 凍結乾燥薬学的組成物、及びその製造及び使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP1980240A1 (enExample) |
| JP (2) | JP2010523678A (enExample) |
| CA (1) | CA2683603A1 (enExample) |
| MX (1) | MX2009010989A (enExample) |
| WO (1) | WO2008127679A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2359812A1 (en) * | 2010-01-18 | 2011-08-24 | Cephalon France | Oral lyophilised compositions |
| WO2011121496A1 (en) | 2010-03-31 | 2011-10-06 | Wockhardt Limited | Composition comprising insulin and herbal oil for transdermal or transmucosal administration |
| GB201007290D0 (en) * | 2010-04-30 | 2010-06-16 | R5 Pharmaceuticals Ltd | Pharmaceutical powder compositions |
| CN102440956B (zh) * | 2011-12-21 | 2013-06-05 | 中国人民解放军第三军医大学 | 自乳化舒马曲坦及其盐制剂的制备方法 |
| FR2987267B1 (fr) * | 2012-02-28 | 2015-01-16 | Debregeas Et Associes Pharma | Application du modafinil dans le traitement de substitution des cacainomanes |
| GR20120100181A (el) * | 2012-03-28 | 2013-10-15 | Μαριαννα Αχιλλεα Παπαμιχαηλ | Νεες λυοφιλοποιημενες φαρμακοτεχνικες και καλυντικοτεχνικες μορφες λυοφιλοποιημενων γαλακτωματων |
| EP2895147B1 (en) * | 2012-09-11 | 2019-06-26 | University Of The Witwatersrand, Johannesburg | Rapidly dissolving pharmaceutical composition |
| LT3220891T (lt) | 2014-11-21 | 2019-11-11 | Biohaven Therapeutics Ltd | Poliežuvinė riluzolio kompozicija |
| EP3368084A4 (en) * | 2015-10-29 | 2019-07-03 | Solubest Ltd | PHARMACEUTICAL COMPOSITIONS FOR TRANSMUCOSAL RELEASE |
| US9650338B1 (en) | 2016-07-29 | 2017-05-16 | VDM Biochemicals, Inc. | Opioid antagonist compounds and methods of making and using |
| CN113784711A (zh) * | 2019-03-12 | 2021-12-10 | 伊登布里奇制药有限公司 | 包含格隆溴铵的口崩片剂和提高生物利用度的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5008A (en) * | 1847-03-13 | Machinery for cleaning | ||
| EP1246668B1 (en) * | 1999-12-01 | 2005-11-30 | Natco Pharma Limited | An rapid acting freeze dired oral pharmaceutical composition for treating migraine |
| US20030068356A1 (en) * | 2001-07-10 | 2003-04-10 | Pather S. Indiran | Sequential drug delivery systems |
| US7846478B2 (en) * | 2002-01-31 | 2010-12-07 | Henkel Ag & Co. Kgaa | Bioadhesive composition |
| NZ540318A (en) * | 2002-10-31 | 2007-09-28 | Umd Inc | Therapeutic compositions for drug delivery to and through covering epithelia |
| KR20050081092A (ko) * | 2004-02-12 | 2005-08-18 | 한국과학기술연구원 | 생체적합성 친수성 고분자를 포함하는 콜로이드계 조성물,제형 및 이들의 제조 방법 |
| WO2006103657A2 (en) * | 2005-03-31 | 2006-10-05 | Dexcel Pharma Technologies Ltd. | A solid composition for intra-oral delivery of insulin |
| WO2007034287A2 (en) * | 2005-09-19 | 2007-03-29 | University Of The Witwatersrand, Johannesburg | Oramucosal pharmaceutical dosage form |
-
2007
- 2007-04-11 EP EP07290443A patent/EP1980240A1/en not_active Withdrawn
-
2008
- 2008-04-11 CA CA002683603A patent/CA2683603A1/en not_active Abandoned
- 2008-04-11 MX MX2009010989A patent/MX2009010989A/es not_active Application Discontinuation
- 2008-04-11 JP JP2010503077A patent/JP2010523678A/ja active Pending
- 2008-04-11 EP EP08742816A patent/EP2152234A1/en not_active Withdrawn
- 2008-04-11 WO PCT/US2008/004755 patent/WO2008127679A1/en not_active Ceased
-
2014
- 2014-08-15 JP JP2014165583A patent/JP2015028030A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010523678A5 (enExample) | ||
| JP6293230B2 (ja) | 経口投与型コルチコステロイド組成物 | |
| AU2011227446B2 (en) | Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form | |
| JP6266075B2 (ja) | 味覚マスキングのためのイオン交換樹脂を含有する可食性経口ストリップ又はウエハース剤形 | |
| US11026883B2 (en) | Lyophilized pharmaceutical compositions for vaginal delivery | |
| JP6154803B2 (ja) | 膣投与のための迅速溶解性錠剤組成物 | |
| JP2006516616A (ja) | 即効薬剤組成物 | |
| FR2781152A1 (fr) | Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation | |
| JP2006516616A5 (enExample) | ||
| JP2018517715A5 (enExample) | ||
| CN108778342B (zh) | 基于环糊精和三氯蔗糖的高生物利用度口腔粘膜药物制剂 | |
| CN105722513A (zh) | 用于嗜酸性粒细胞性食管炎的包含皮质类固醇的经口崩解片剂组合物 | |
| EP1465593B1 (fr) | Forme pharmaceutique solide orodispersible | |
| CA2858478C (en) | Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of manufacturing | |
| JP2015028030A (ja) | 凍結乾燥薬学的組成物、及びその製造及び使用方法 | |
| CN104869983A (zh) | 醋酸格拉替雷的透粘膜给药 | |
| Clementino et al. | Polysaccharides: New frontiers for nasal administration of medicines | |
| Chowrasia et al. | Current drug delivery strategies to design orally dissolving formulations to target tuberculosis: A futuristic review | |
| US20050281873A1 (en) | Universal controlled-release composition | |
| EP3082791B1 (fr) | Compositions pharmaceutiques orales à rétention gastrique à base de baclofène | |
| JP6513702B2 (ja) | 超速崩壊錠剤及びその製造方法 | |
| TW200948398A (en) | Vancomycin hydrochloride tablet | |
| US20130143912A1 (en) | Sublingual zolpidem formulations | |
| HK1181298B (en) | Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form | |
| HK1181298A (en) | Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form |